NO304597B1 - Arylalkoxyfenoxy-imidazolinforbindelser - Google Patents

Arylalkoxyfenoxy-imidazolinforbindelser

Info

Publication number
NO304597B1
NO304597B1 NO942917A NO942917A NO304597B1 NO 304597 B1 NO304597 B1 NO 304597B1 NO 942917 A NO942917 A NO 942917A NO 942917 A NO942917 A NO 942917A NO 304597 B1 NO304597 B1 NO 304597B1
Authority
NO
Norway
Prior art keywords
imidazoline
arylalkoxyfenoxy
arylalkoxyphenoxy
anxiety
hypertension
Prior art date
Application number
NO942917A
Other languages
English (en)
Norwegian (no)
Other versions
NO942917D0 (es
NO942917L (no
Inventor
Jules Freedman
Bruce M Baron
Mark William Dudley
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/832,556 external-priority patent/US5216008A/en
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO942917D0 publication Critical patent/NO942917D0/no
Publication of NO942917L publication Critical patent/NO942917L/no
Publication of NO304597B1 publication Critical patent/NO304597B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Reinforced Plastic Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
NO942917A 1992-02-06 1994-08-05 Arylalkoxyfenoxy-imidazolinforbindelser NO304597B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/832,556 US5216008A (en) 1992-02-06 1992-02-06 Arylalkoxyphenoxy-imidazoline compounds
US99017492A 1992-12-24 1992-12-24
PCT/US1993/000238 WO1993016051A1 (en) 1992-02-06 1993-01-12 Arylalkoxyphenoxy-imidazoline compounds

Publications (3)

Publication Number Publication Date
NO942917D0 NO942917D0 (es) 1994-08-05
NO942917L NO942917L (no) 1994-08-05
NO304597B1 true NO304597B1 (no) 1999-01-18

Family

ID=27125545

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942917A NO304597B1 (no) 1992-02-06 1994-08-05 Arylalkoxyfenoxy-imidazolinforbindelser

Country Status (19)

Country Link
US (1) US5407954A (es)
EP (1) EP0625969B1 (es)
JP (1) JPH07504167A (es)
KR (1) KR100276994B1 (es)
AT (1) ATE199547T1 (es)
CA (1) CA2129142A1 (es)
DE (1) DE69329994T2 (es)
DK (1) DK0625969T3 (es)
ES (1) ES2156868T3 (es)
FI (1) FI943637A (es)
GR (1) GR3035915T3 (es)
HU (1) HUT67527A (es)
IL (2) IL104600A0 (es)
MX (1) MX9300601A (es)
NO (1) NO304597B1 (es)
NZ (1) NZ246823A (es)
PT (1) PT625969E (es)
TW (1) TW366338B (es)
WO (1) WO1993016051A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000877A1 (en) * 1989-07-06 1991-01-24 Eastman Kodak Company Maleated polypropylene blends for melt-bonding applications
CA3025884C (en) * 2016-06-24 2023-03-07 Ohio University Glucose transport inhibitors and methods of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695555A1 (de) * 1967-02-23 1970-07-16 Nordmark Werke Gmbh Neue Aryloxy-isoalkyl-delta2-imidazoline und deren Saeureadditionssalze sowie Verfahren zu ihrer Herstellung
CA2027530C (en) * 1989-10-20 2001-05-08 Jules Freedman W-phenoxy-heterocyclic compounds

Also Published As

Publication number Publication date
AU671270B2 (en) 1996-08-22
JPH07504167A (ja) 1995-05-11
GR3035915T3 (en) 2001-08-31
DE69329994T2 (de) 2001-06-28
FI943637A0 (fi) 1994-08-05
ES2156868T3 (es) 2001-08-01
HU9402283D0 (en) 1994-10-28
FI943637A (fi) 1994-08-05
ATE199547T1 (de) 2001-03-15
NO942917D0 (es) 1994-08-05
CA2129142A1 (en) 1993-08-19
AU3442293A (en) 1993-09-03
PT625969E (pt) 2001-08-30
TW366338B (en) 1999-08-11
MX9300601A (es) 1993-08-01
DK0625969T3 (da) 2001-04-30
IL104600A0 (en) 1993-06-10
US5407954A (en) 1995-04-18
EP0625969A1 (en) 1994-11-30
IL122537A0 (en) 1998-06-15
HUT67527A (en) 1995-04-28
EP0625969B1 (en) 2001-03-07
KR100276994B1 (ko) 2002-06-20
NZ246823A (en) 1996-06-25
KR950700260A (ko) 1995-01-16
DE69329994D1 (en) 2001-04-12
WO1993016051A1 (en) 1993-08-19
NO942917L (no) 1994-08-05

Similar Documents

Publication Publication Date Title
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
SE9502893L (sv) Användning av kollagenas
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
ATE103594T1 (de) Fucosidase-inhibitoren.
DE69230224D1 (de) Potenzierung von nmda-antagonisten
NO984245D0 (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse
DK0625969T3 (da) Arylalkoxyphenoxyimidazolinforbindelser
FI953002A (fi) Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla
DK1019347T3 (da) Fremgangsmåde til syntesen af taxaner
ATE267209T1 (de) Reinigung von carboxaldehyd
ATE144899T1 (de) Derivate des 1-piperidinyl- alkanoylarylsulfonamids
NO954115L (no) Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis
UA40497A (uk) Спосіб лікування генералізованого катарального гінгівіту
MX9706424A (es) Uso de la moxonidina para el tratamiento de la aterosclerosis.